DrugBank ID: db00281
Synonymous :2-(diethylamino)-2’,6’-acetoxylidide | 2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide | alpha-diethylamino-2,6-dimethylacetanilide | lidocaína | lidocaina | lidocaine | lidocainum | lignocaine | α-diethylamino-2,6-dimethylacetanilide
Drug Sentece Context
Table 1. Analysis of context sentence of lidocaine gene in 3 abstracts.
|32335946||Given the current pandemic situation of COVID-19, the Japan Gastroenterological Endoscopy Society issued the recommendation for gastrointestinal (GI) endoscopy based on the status of COVID-19 as of April 9, 2020, in Japan: (i) indications for GI endoscopy in the pandemic of COVID-19; (ii) practical protective equipment for medical personnel depending on the risk for COVID-19; (iii) preprocedural management, such as pharyngeal local anesthesia using lidocaine spray which has a potential to generate the aerosols; (iv) ideal settings of the endoscopy room including the numbers of the staff and the patients; (v) postprocedural management, such as undressing and follow-up of the patients, as well as the involved staff, were documented to fit the practical scenarios in GI endoscopy, with the available data in Japan and the world.|
|32505070||Lidocaine, a local analgesic and anti-arrhythmic, is known for its anti-inflammatory actions and has been used to reduce cough and improve respiratory symptoms in severe asthmatic patients. […] It is proposed that nebulized lidocaine might be beneficial in reducing cytokines, protecting patients’ lungs and improving outcomes in COVID-19 patients when administered via inhalation as an adjunctive treatment for severe respiratory symptoms in patients fighting the novel Coronavirus.|